Neurocirculatory Asthenia
Eponyms
Sympathetic Nervous System
Cardiac anxiety in people with and without coronary atherosclerosis. (1/9)
Many studies have shown that cardiac anxiety when occurring in the absence of coronary artery disease is common and quite costly. The Cardiac Anxiety Questionnaire (CAQ) is an 18-item self-report measure that assesses anxiety related to cardiac symptoms. To better understand the construct of cardiac anxiety, a factor analysis was conducted on CAQ data from 658 individuals who were self or physician-referred for electron beam tomographic screening to determine whether clinically significant coronary atherosclerosis was present. A four-factor solution was judged to provide the best fit with the results reflecting the following factor composition: heart-focused attention, avoidance of activities that bring on symptoms, worry or fear regarding symptoms, and reassurance-seeking. Factorial invariance across groups was also assessed to determine whether the factor structure of the CAQ was similar in individuals with and without clear evidence of coronary atherosclerosis. The factor structure of the CAQ did not differ between the two groups. However, the group without coronary atherosclerosis had significantly higher mean scores on their attention and worry/fear factors suggesting that people without a diagnosed cardiac condition pay more attention to and worry more about their cardiac-related symptoms than those people who have coronary atherosclerosis. (+info)False heart rate feedback and the perception of heart symptoms in patients with congenital heart disease and anxiety. (2/9)
(+info)Cardiac function fluctuates during exacerbation and remission in young adults with chronic fatigue syndrome and "small heart". (3/9)
(+info)Cardiac neurosis: exercise tolerance and the role of sympathetic activity. (4/9)
To evaluate the cardiovascular and plasma catecholamine responses to dynamic exercise in patients with cardiac neurosis (CN), treadmill testing was performed. Thirty-four patients with CN were chosen for this study based on exercise tolerance and the results were compared with those in 31 patients with organic heart disease and 12 normal subjects. Patients with CN showed an augmentation of cardiovascular and plasma catecholamine responses. The augmentation of the norepinephrine response in patients with CN was not as remarkable as that in patients with organic heart disease. On the other hand, the augmentation of the epinephrine response was greater in patients with CN than in those with organic heart disease. Administration of metoprolol (40 mg/day) for two weeks improved exercise tolerance in patients with CN. We suggest that anxiety augments both sympatho-neural and sympatho-adrenal activity and that it is the symptoms induced by the augmented cardiovascular response which reduce exercise tolerance in patients with CN. (+info)Is chronic fatigue syndrome synonymous with effort syndrome? (5/9)
Chronic fatigue syndrome (CFS), including myalgic encephalomyelitis (ME) and postviral syndrome (PVS), is a term used today to describe a condition of incapacity for making and sustaining effort, associated with a wide range of symptoms. None of the reviews of CFS has provided a proper consideration of the effort syndrome caused by chronic habitual hyperventilation. In 100 consecutive patients, whose CFS had been attributed to ME or PVS, the time course of their illness and the respiratory psychophysiological studies were characteristic of chronic habitual hyperventilation in 93. It is suggested that the labels 'CFS', 'ME' or 'PVS' should be withheld until chronic habitual hyperventilation - for which conventional rehabilitation is available - has been definitively excluded. (+info)Failure of perception of hypocapnia: physiological and clinical implications. (6/9)
Hyperventilation causes hypocapnia and respiratory alkalosis and thereby predisposes to coronary vasoconstriction and cardiac arrhythmia. Diagnostic methods for use between episodes have not been established. In this study of 100 patients and 25 control subjects the resting end-tidal PCO2 (Pet CO2) levels and the results of a forced hyperventilation test did not show a significant difference between the groups. However the patients hyperventilated more profoundly in response to emotional stimulation, and were less aware of inappropriate breathing and hypocapnia. It is suggested that these differences should be accommodated in cardiac rehabilitation. (+info)Normal muscle strength and fatigability in patients with effort syndromes. (7/9)
To examine fatigue mechanisms in an unselected series of patients with excess fatigue ("effort syndromes") their muscle function was compared with that of normal subjects. Voluntary performance was assessed with a cycle ergometer to exhaustion and by maximal isometric contractions of the quadriceps femoris. The mean maximal heart rate in patients during ergometry was 89% of the predicted rate, and quadriceps strength was either normal or was inappropriate for the available muscle, which suggested submaximal effort. Contractile performance was examined in the absence of volition with stimulated contractions of the adductor pollicis. During stimulated fatiguing activity patients were neither weaker nor more fatigable than controls; thus the excess fatigue experienced by the patients was not due to a defect of the contractile apparatus. The increased perception of effort must therefore be due to impairment of central rather than peripheral mechanisms. The optimal approach to treatment of effort syndromes combines physical and psychological techniques. (+info)Da Costa's syndrome or neurocirculatory asthenia. (8/9)
The syndrome variously called Da Costa's syndrome, effort syndrome, neurocirculatory asthenia, etc has been studied for more than 100 years by many distinguished physicians. Originally identified in men in wartime, it has been widely recognised as a common chronic condition in both sexes in civilian life. Although the symptoms may seem to appear after infections and various physical and psychological stresses, neurocirculatory asthenia is most often encountered as a familial disorder that is unrelated to these factors, although they may aggravate an existing tendency. Respiratory complaints (including breathlessness, with and without effort, and smothering sensations) are almost universal, and palpitation, chest discomfort, dizziness and faintness, and fatigue are common. The physical examination is normal. The aetiology is obscure but patients usually have a normal life span. Reassurance and measures to improve physical fitness are helpful. (+info)Neurocirculatory asthenia is not a term that is widely used in modern medicine. However, historically, it has been used as a descriptive diagnosis for a group of symptoms characterized by fatigue, weakness, dizziness, and disturbances of heart rate and blood pressure, often in response to emotional stress or physical exertion.
The term "neurocirculatory" refers to the interaction between the nervous system and the cardiovascular system, while "asthenia" is a general term used to describe a lack of energy or weakness.
In modern medicine, this condition may be diagnosed as a form of functional disorder, neurasthenia, or somatic symptom disorder, depending on the specific symptoms and underlying causes. It's important to note that while these symptoms can be real and debilitating, they do not have a clear organic cause, and treatment typically focuses on managing symptoms and addressing any underlying psychological or emotional factors.
An eponym is a name derived from a person, usually the person who first described a medical condition or invention. In medicine, eponyms are often used to describe specific signs, symptoms, conditions, or diagnostic tests. For example, Alzheimer's disease is named after Alois Alzheimer, who first described the condition in 1906. Similarly, Parkinson's disease is named after James Parkinson, who first described it in 1817.
Eponyms can be helpful in medical communication because they provide a quick and easy way to refer to specific medical concepts. However, they can also be confusing or misleading, especially when the eponym's origin is not well-known or when different eponyms are used for the same concept. Therefore, it is essential to use eponyms appropriately and understand their underlying medical concepts.
Asthenia is a medical term that refers to a condition of unusual physical weakness or exhaustion that is not relieved by rest. It can be a symptom of various underlying health issues, such as infections, neurological disorders, endocrine diseases, and mental health conditions. Asthenia should not be confused with general fatigue or tiredness, as it is more severe, persistent, and debilitating.
The term "asthenia" comes from the Greek words "a" (without) and "sthenos" (strength), which together mean "without strength." In medical contexts, asthenia is often used to describe a significant decrease in muscle strength or energy levels that interferes with daily activities and reduces the overall quality of life.
Asthenia can manifest as a general feeling of weakness, fatigue, lethargy, or lack of stamina. In some cases, it may be accompanied by other symptoms such as dizziness, lightheadedness, headaches, irritability, and depression. Depending on the underlying cause, asthenia may be treated with various interventions, including medication, lifestyle changes, physical therapy, or counseling.
The sympathetic nervous system (SNS) is a part of the autonomic nervous system that operates largely below the level of consciousness, and it functions to produce appropriate physiological responses to perceived danger. It's often associated with the "fight or flight" response. The SNS uses nerve impulses to stimulate target organs, causing them to speed up (e.g., increased heart rate), prepare for action, or otherwise respond to stressful situations.
The sympathetic nervous system is activated due to stressful emotional or physical situations and it prepares the body for immediate actions. It dilates the pupils, increases heart rate and blood pressure, accelerates breathing, and slows down digestion. The primary neurotransmitter involved in this system is norepinephrine (also known as noradrenaline).